Literature DB >> 21798745

The death-fold superfamily of homotypic interaction motifs.

Kristof Kersse1, Jelle Verspurten, Tom Vanden Berghe, Peter Vandenabeele.   

Abstract

The death-fold superfamily encompasses four structurally homologous subfamilies that engage in homotypic, subfamily-restricted interactions. The Death Domains (DDs), the Death Effector Domains (DEDs), the CAspase Recruitment Domains (CARDs) and the PYrin Domains (PYDs) constitute key building blocks involved in the assembly of multimeric complexes implicated in signaling cascades leading to inflammation and cell death. We review the molecular basis of these homotypic domain-domain interactions in light of their structure, function and evolution. In addition, we elaborate on three distinct types of asymmetric interactions that were recently identified from the crystal structures of three multimeric, death-fold complexes: the MyDDosome, the PIDDosome and the Fas/FADD-DISC. Insights into the mechanisms of interaction of death-fold domains will be useful to design strategies for specific modulation of complex formation and might lead to novel therapeutic applications.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798745     DOI: 10.1016/j.tibs.2011.06.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  58 in total

1.  The Inflammasome Adaptor ASC Induces Procaspase-8 Death Effector Domain Filaments.

Authors:  Parimala R Vajjhala; Alvin Lu; Darren L Brown; Siew Wai Pang; Vitaliya Sagulenko; David P Sester; Simon O Cridland; Justine M Hill; Kate Schroder; Jennifer L Stow; Hao Wu; Katryn J Stacey
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

Review 2.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

3.  ASC Pyrin Domain Self-associates and Binds NLRP3 Protein Using Equivalent Binding Interfaces.

Authors:  Javier Oroz; Susana Barrera-Vilarmau; Carlos Alfonso; Germán Rivas; Eva de Alba
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

Review 4.  Inhibiting the inflammasome: one domain at a time.

Authors:  Andrea Dorfleutner; Lan Chu; Christian Stehlik
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

5.  Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation.

Authors:  Elfriede Dall; Hans Brandstetter
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

6.  Structure of the caspase-recruitment domain from a zebrafish guanylate-binding protein.

Authors:  Tengchuan Jin; Mo Huang; Patrick Smith; Jiansheng Jiang; T Sam Xiao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-07-27

7.  The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces.

Authors:  Tengchuan Jin; Mo Huang; Patrick Smith; Jiansheng Jiang; T Sam Xiao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-04-27

Review 8.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

9.  Crystal structure of the F27G AIM2 PYD mutant and similarities of its self-association to DED/DED interactions.

Authors:  Alvin Lu; Venkataraman Kabaleeswaran; Tianmin Fu; Venkat Giri Magupalli; Hao Wu
Journal:  J Mol Biol       Date:  2014-01-07       Impact factor: 5.469

10.  Structure of the absent in melanoma 2 (AIM2) pyrin domain provides insights into the mechanisms of AIM2 autoinhibition and inflammasome assembly.

Authors:  Tengchuan Jin; Andrew Perry; Patrick Smith; Jiansheng Jiang; T Sam Xiao
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.